Target Healthcare Sectors
Healthcare. It's our passion
Ampersand has over two decades of experience in helping build middle market healthcare companies into market leaders.
and our expertise.
We focus on EBITDA-positive companies that provide products or services within several key healthcare sectors, including laboratory testing services, laboratory products, contract manufacturing, pharma services, specialty pharma and healthcare services. Ampersand brings significant prior experience to each of these sectors, allowing us to partner with entrepreneurs in taking their companies to the next level.
Our portfolio companies are moving forward in dynamic ways.
Laboratory ProductsAmpersand has more than 20 years of experience investing in companies that provide innovative products to the laboratory industry. Our current and past portfolio companies include leading producers of consumables and instruments used in both research and diagnostic laboratories around the world.
Laboratory ServicesAmpersand has worked with entrepreneurs to help build several leading specialty laboratories with a focus on laboratory testing services for clinical diagnostics, regulatory testing and manufacturing support.
Contract ManufacturingAmpersand has a long history of investing in contract manufacturing businesses, including manufacturers of pharmaceuticals, nutritional ingredients, nutraceuticals, and medical devices and components. Contract manufacturers play an essential role in the healthcare sector, enabling pharmaceutical and medical device companies to operate in a more lean and efficient manner.
Pharma ServicesOver the last decade, Ampersand has invested in numerous pharma services companies, with a focus on service providers that address specialized needs not addressed by large CROs. Ampersand has been successful at helping these companies grow by adding new services and completing add-on acquisitions.
Specialty PharmaWithin the specialty pharma space, Ampersand has focused on segments where industrialization themes can be leveraged to create value. Further, we have expertise within the specialty pharmacy and distribution sides of the industry.
We have a a strong track record of being good partners and adding value to our portfolio companies.
Company SizeTypically $10 to $100 million of revenue
Investment size$10 to $100 million of equity
Use of leverage when appropriate
OwnershipEither majority or minority positions
RoleFirst institutional investor
Use of captialBusiness expansion / growth equity
Recapitalizations / shareholder equity
Target Healthcare SectorsLaboratory Products